Package 72162-2216-1

Brand: lisdexamfetamine dimesylate

Generic: lisdexamfetamine dimesylate
NDC Package

Package Facts

Identity

Package NDC 72162-2216-1
Digits Only 7216222161
Product NDC 72162-2216
Product ID 72162-2216_a0de8320-488d-4cd2-b976-68067f7222fe
Description

100 CAPSULE in 1 BOTTLE (72162-2216-1)

Marketing

Marketing Status
Marketed Since 2024-01-05
Brand lisdexamfetamine dimesylate
Generic lisdexamfetamine dimesylate
Sample Package No

Linked Drug Pages (1)

lisdexamfetamine dimesylate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a0de8320-488d-4cd2-b976-68067f7222fe", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854834"], "spl_set_id": ["7d80e121-88d4-4e65-b60e-05e713368d4b"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (72162-2216-1)", "package_ndc": "72162-2216-1", "marketing_start_date": "20240105"}], "brand_name": "lisdexamfetamine dimesylate", "product_id": "72162-2216_a0de8320-488d-4cd2-b976-68067f7222fe", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "72162-2216", "dea_schedule": "CII", "generic_name": "lisdexamfetamine dimesylate", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lisdexamfetamine dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "30 mg/1"}], "application_number": "ANDA214547", "marketing_category": "ANDA", "marketing_start_date": "20230825", "listing_expiration_date": "20261231"}